30 March 2023
CENTRAL ASIA METALS PLC
('CAML' or the 'Company')
Share Purchase by Director
The Company (AIM:CAML) was notified on 29 March 2023 that, on the same day, Dr Mike Armitage, a Non-Executive Director, purchased 8,334 ordinary shares of US$0.01 each ('Shares') in the Company at a price of £2.40 per Share. The Shares were purchased on the open market.
Following this acquisition, Dr Mike Armitage owns a total of 24,490 Shares representing 0.013% of the issued share capital of the Company (excluding shares held in treasury).
For further information contact:
| Central Asia Metals |
|
| Tony Hunter, Company Secretary | Tel: +44 (0) 20 7603 1515 |
| Louise Wrathall, Director of Corporate Relations | louise.wrathall@centralasiametals.com |
|
|
|
| Peel Hunt (Nominated Adviser and Joint Broker) | Tel: +44 (0) 20 7418 8900 |
| Ross Allister |
|
| David McKeown |
|
|
|
|
| BMO Capital Markets (Joint Broker) | Tel: +44 (0) 20 7236 1010 |
| Thomas Rider |
|
| Pascal Lussier Duquette |
|
|
|
|
| BlytheRay (PR Advisors) | Tel: +44 (0) 20 7138 3204 |
| Tim Blythe |
|
| Megan Ray |
|
| Rachael Brooks |
|
Note to editors:
Central Asia Metals, an AIM-listed UK company based in London, owns 100% of the Kounrad SX-EW copper project in central Kazakhstan and 100% of the Sasa zinc-lead mine in North Macedonia.
For further information, please visit www.centralasiametals.com and follow CAML on Twitter at @CamlMetals and on LinkedIn at Central Asia Metals Plc.
| 1. | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Dr Mike Armitage | |
| 2. | Reason for the Notification | ||
| a) | Position/status | Non-Executive Director | |
| b) | Initial notification/amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Central Asia Metals plc | |
| b) | LEI | 213800EYQBJZIT64NH43 | |
| 4. | Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted | ||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of US$0.01 each | |
| Identification code | GB00B67KBV28 | ||
| b) | Nature of the Transaction | Acquisition of Shares | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| | £2.40 | 8,334 | |
| d) | Aggregated information - Aggregated volume
- Price |
N/A (Single transaction) | |
| e) | Date of the transaction | 29 March 2023 | |
| f) | Place of the transaction | XLON
| |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.